Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Hippieslayer who wrote (9862)	10/21/1997 9:38:00 AM
From: Henry Niman	Read Replies (1) \| Respond to of 32384

Stephen, I don't think that the thread was used as a news source for yesterday's article. Although the article mentioned widespread aticipation, I don't think that the reference was to this thread. At least 4 of the 5 brokerage houses (Lehman Brothers, Roberston Stephens, Hambrecht & Quist, and Bear Stearns) that cover LGND put out reiterated BUYS on LGND either just before the the ALRI buyback announcement or just after. All of these reports as well as several wire service reports (including the Robinson interview by Reuter's) discussed the diabetes deal as did Jesse Eisinger's earlier report on LGND, which did mention the thread, so it was clearly "widely anticipated".